Alkermes Inc., of Cambridge, Mass., elected Gerri Henwood and Paul Mitchell to its board.

Antisoma plc, of London, promoted Nigel Courtenay-Luck to chief scientific officer.

Aphton Corp., of Miami, added Patrick Mooney as chief medical officer.

Applied DNA Sciences Inc., of Los Angeles, appointed Jeffry Brown to its board of advisors and he will be a strategic business consultant.

BioMarker Pharmaceuticals Inc., of Campbell, Calif., added Michael West to its board.

Biomira Inc., of Edmonton, Alberta, promoted Marilyn Olson to vice president, regulatory affairs.

Corgentech Inc., of Palo Alto, Calif., promoted Patricia Oto to vice president for regulatory affairs and quality assurance.

Crucell N.V., of Leiden, the Netherlands, named C.E. Wilhelmsson and S. Lance to its supervisory board.

Cytos Biotechnology AG, of Zurich-Schlieren, Switzerland, elected Jean-Yves le Cotonnec, Thomas Hecht and Thorlef Spickschen as members of its board.

Deltagen Inc., of Redwood City, Calif., will name John Varian chief financial officer.

DepoMed Inc., of Menlo Park, Calif., elected Michael Callaghan to its board.

Dynal Biotech ASA, of Oslo, Norway, appointed Erik Hornes vice president, technology development and chief scientific officer.

Ecopia BioSciences Inc., of Montreal, appointed Gervais Dionne and Louis de Repentigny to its scientific advisory board.

Exact Sciences Corp., of Maynard, Mass., added Patrick Zenner to its board.

GenPath Pharmaceuticals Inc., of Cambridge, Mass., added Elan Ezickson as chief business officer.

Lexicon Genetics Inc., of The Woodlands, Texas, added Philip Brown as vice president of clinical development.

MacroChem Corp., of Lexington, Mass., appointed Thomas Chan vice president of research and development, chief technology officer.

Novuspharma SpA, of Milan, Italy, said shareholders approved the appointment of David Ebsworth as a non-executive director.

Osiris Therapeutics Inc., of Baltimore, elected James Tobin to its board.

Paladin Labs Inc., of Montreal, appointed Aldo Baumgartner and Michael Cloutier to its board.

Prometheus Laboratories Inc., of San Diego, appointed Augustine Yee vice president, corporate development.

Pyrosequencing AB, of Uppsala, Sweden, elected Jeff Bork to its board and intends to name him chairman.

Sepracor Inc., of Marlborough, Mass., appointed Mark Corrigan executive vice president of research and development.

Serologicals Corp., of Atlanta, appointed James Kramer vice president, global manufacturing operations and Cyndi Tolman managing director, plasma operations.

Southern Research Institute, of Birmingham, Ala., added Gary Piazza as manager of cell biology and immunology in the cancer therapeutics and immunology deptartment of the drug development division.

The Medicines Co., of Parsippany, N.J., elected William Crouse, Robert Hugin and Robert Savage to its board.